Recap: Redhill Biopharma Q1 Earnings

 

Redhill Biopharma RDHL reported its Q1 earnings results on Thursday, June 23, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Redhill Biopharma reported an EPS of $0.03.

Revenue was down $2.34 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.28 which was followed by a 12.72% increase in the share price the next day.

Here's a look at Redhill Biopharma's past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.33 -0.21 -0.12 -0.34
EPS Actual -0.05 -0.50 -0.06 -0.05
Revenue Estimate 24.08M 24.52M 25.02M 22.70M
Revenue Actual 22.07M 21.61M 21.50M 20.57M

To track all earnings releases for Redhill Biopharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!